- Home
- PTIX vs GIPR Comparison
PTIX vs GIPR Comparison
Compare PTIX & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- GIPR
- Stock Information
- Founded
- PTIX 1994
- GIPR 2015
- Country
- PTIX United States
- GIPR United States
- Employees
- PTIX N/A
- GIPR N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- GIPR Real Estate Investment Trusts
- Sector
- PTIX Health Care
- GIPR Real Estate
- Exchange
- PTIX Nasdaq
- GIPR Nasdaq
- Market Cap
- PTIX 6.3M
- GIPR 6.4M
- IPO Year
- PTIX 2016
- GIPR 2021
- Fundamental
- Price
- PTIX $2.05
- GIPR $0.94
- Analyst Decision
- PTIX
- GIPR
- Analyst Count
- PTIX 0
- GIPR 0
- Target Price
- PTIX N/A
- GIPR N/A
- AVG Volume (30 Days)
- PTIX 71.8K
- GIPR 123.8K
- Earning Date
- PTIX 11-28-2025
- GIPR 11-17-2025
- Dividend Yield
- PTIX N/A
- GIPR N/A
- EPS Growth
- PTIX N/A
- GIPR N/A
- EPS
- PTIX N/A
- GIPR N/A
- Revenue
- PTIX N/A
- GIPR $9,953,920.00
- Revenue This Year
- PTIX N/A
- GIPR $1.12
- Revenue Next Year
- PTIX N/A
- GIPR $0.52
- P/E Ratio
- PTIX N/A
- GIPR N/A
- Revenue Growth
- PTIX N/A
- GIPR N/A
- 52 Week Low
- PTIX $1.83
- GIPR $0.78
- 52 Week High
- PTIX $14.28
- GIPR $2.06
- Technical
- Relative Strength Index (RSI)
- PTIX 41.67
- GIPR 36.92
- Support Level
- PTIX $1.83
- GIPR $1.24
- Resistance Level
- PTIX $2.11
- GIPR $1.13
- Average True Range (ATR)
- PTIX 0.18
- GIPR 0.10
- MACD
- PTIX 0.02
- GIPR -0.04
- Stochastic Oscillator
- PTIX 49.13
- GIPR 0.25
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.